维普期刊资源整合服务平台（V6.5）

37篇 您的检索式：作者名="Judson P"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Characterizing the efficacy of fermented wheat germ extract against ovarian cancer and defining the genomic basis of its activity显示文摘	Judson P L		0，，06：	1
2	A prospective randomized trial of thalidomide with topotecan compared with topotecan alone in women with recurrent epithelial ovarian carcinoma显示文摘	Downs L S Jr Judson P L Argenta P A	2008	Cancer2008，112，2：	1
3	Maternal plasmasoluble fms-like tyrosine kinase-1 and placental growth factorlevels as biochemical markers of gestational hypertension forMalaysian mothers 显示文摘	Nadarajah V D* Min R G Judson J P?	2009	Obstet Gynaecol Res2009，35，5：	1
4	Lymphopenia as a prognostic factor for overall survival in advanced carcinomas,sarcomas,and lymphomas显示文摘	Ray-Coquard I Cropet C Van Glabbeke M Sebban C Le Cesne A Judson I Tredan O Verweij J Biron P Labidi I Guastalla JP Bachelot T Perol D Chabaud S Hogendoorn PCW Cassier P Dufresne A Blay JY	2009	Cancer Res2009，69，13：	1
5	Cisplatininhib its paclitaxel induced apoptos is in cisplatinresistant ovarian can cer cell 1 ines : possible explanation for failure of comb inatian ther- apy显示文摘	JUDSON P L WATSON J M GEHRIG P A	1999	Cancer Res1999，59，10：	1
6	Yap is a novel regulator of C2C12 myogenesis显示文摘	Watt K I Judson R Medlow P	2010	Biochem Biophys Res Commnn2010，393，4：	1
7	Effect of gastric pH on the relative oral bioavailability and pharmacokinetics of temozolomide显示文摘	Beale P Judson I Moore S	1999	Cancer Chemother Pharmacol1999，44，5：	1
8	Cisplatin inhibits paelitaxel-indueed apoptosis in cisplatin-resistant ovarian cancer cell lines: possible explanation for failure of combi- nation therapy显示文摘	JUDSON P L WATSON J M GEHRIG P A	1999	Cancer Research1999，59，10：	1
9	Effects of impaired renal function on the pharmacokinetics of raltitrexed (Tomudex ZDI 694)显示文摘	I Judson T Maughan P Beale	1998	Sri J Cancer1998，78，9：	1
10	Trends in the incidence of invasive and in situ vulvar carcinoma显示文摘	Judson P L Habermann E B Baxter N N	2006	Obstet Gynecol2006，107，5：	1
11	A phase Ⅱ study of allogeneic natural k{ller cell therapy to treat patients with recurrent ovarian and breast cancer 显示文摘	GELLER M A COOLEY S JUDSON P L	2011	Cytotherapy2011，13，1：	1
12	Plasma,liver and fat alpha tocopherol concentrations in sheep given various oral and subcutaneous doses of vitamin E显示文摘	Judson G J Babidge P J Babidge W J	1991	Aust J Exp Agric1991，31，：	1
13	A phase Ⅰ clinica and pharmacological study of cis-diamminedichloro (2-methyloyidine) platinum Ⅱ(AMD473)显示文摘	Beale P Judson I O'Donnell A	2003	Br J Cancer2003，88，7：	1
14	Efficacy and tolerability of lower-dose topotecan in recurrent ovarian cancer:a retrospective case review显示文摘	Mitchell SK Carson LF Judson P	2005	Int J Gynecol Cancer2005，15，5：	1
15	Outcome of hepatitis B virus infection in homosexual men and its relation to prior HIV infection显示文摘	Hadler S Judson F O' Malley P	1991	J Infect Dis1991，163，：	1
16	Metabolism, excretion and pharmacokinetics of a single dose of -raltitrexed in cancer patients显示文摘	JUDSON I HANWELL J	1998	Cancer Chemother Pharmacol1998，42，1：	1
17	Effects of impaired renal function on the pharmacokinetics of raltitrexed (Tomudex ZD1694)显示文摘	Judson I Maughan T Beale P	1998	Br J Cancer1998，78，9：	1
18	Reconstructive application of the endotine suspension devices显示文摘	BOEHMLER J H 4th JUDSON B L DAVISON S P	2007	Arch Facial Plast Surg2007，9，5：	1
19	Plasma, liver and fat alpha-tocopherol concentrations in sheep given various oral and subcutaneous doses of vitamin E显示文摘	Judson G J Babidge P J Babidge W J	1991	Aust J Exp Agric1991，31，：	1
20	Phase I dose-escalation and pharmacokinetic study of temozolomide (SCH52365) for refractory or relapsing malignancies显示文摘	Brada M Judson I Brale P	1999	Br J Cancer1999，81，6：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示